Latest Renal cell carcinoma Stories
Incentives for Pathway Compliance, Reduced Hospitalization are Changing Treatment, According to Findings from Decision Resources Group BURLINGTON, Mass., March 4, 2014 /PRNewswire/ -- Decision
SAN DIEGO and OSAKA, Japan, March 4, 2014 /PRNewswire/ -- TRACON Pharmaceuticals (TRACON) and Santen Pharmaceutical Co., Ltd.
SOUTH SAN FRANCISCO, Calif., Feb.
Tokyo, Feb 3, 2014 - (JCN Newswire) - Eisai Co., Ltd.
Study shows impact of educational programs and clinical tools on the treatment of renal cell carcinoma RESTON, Va., Jan.
DURHAM, N.C., Jan.
Scientists in Japan and Austria say the kinase inhibitor temsirolimus stops mesothelioma growth in two different ways. Raleigh, NC (PRWEB) January 04, 2014
A recent study featured in the latest issue of The Oncologist shows that active smoking greatly diminishes patients’ chances of responding to chemotherapeutic treatment for renal cell carcinoma